涉及阿片类、可卡因和兴奋剂的过量死亡——美国,2015-2016年
美国2016年共发生63,632例药物过量死亡,其中42,249例(66.4%)涉及阿片类。2015至2016年所有 examined 药物类别死亡均增加,可卡因相关年龄调整死亡率上升52.4%,合成阿片类(除美沙酮外)上升100%,可能由非法制造芬太尼驱动。阿片类过量流行持续恶化,需多层面应对。
要点
- 2016年美国药物过量死亡63,632例,66.4%涉及阿片类。
- 2015至2016年可卡因相关死亡率上升52.4%,合成阿片类上升100%。
- 需加强监测并采取纳洛酮可及、安全处方、减害服务等多层面措施。
核心结论
- 美国阿片类过量死亡流行持续恶化,2015至2016年所有 examined 药物类别死亡均增加,需多层面应对。
研究设计与样本
- CDC分析了2015至2016年美国全部阿片类、阿片类亚类(处方阿片类、海洛因、合成阿片类)、可卡因及具滥用潜力的精神兴奋剂过量死亡的年龄调整死亡率,按人口学、城市化水平及31个州和哥伦比亚特区进行。
主要发现
- 2016年美国药物过量死亡63,632例,其中42,249例(66.4%)涉及阿片类。
- 2015至2016年,可卡因相关过量死亡年龄调整死亡率上升52.4%,合成阿片类(除美沙酮外)上升100%。
- 2014至2015年,合成阿片类(除美沙酮外)相关死亡年龄调整死亡率上升72.2%,为最大增幅。
- 2015年美国药物过量死亡52,404例,其中33,091例(63.1%)涉及阿片类;2014至2015年药物过量死亡增加11.4%。
- 2015至2016年死亡增加在人口学、城市化水平及州和哥伦比亚特区均有观察。
临床怎么用
- 需通过纳洛酮可及性、安全处方实践、减害服务、 linkage into treatment 以及公共卫生与公共安全机构间更多合作,以预防和应对过量流行。
- 需更快、更全面的监测以追踪新出现的威胁。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During 1999‒2015, 568,699 persons died from drug overdoses in the United States.* Drug overdose deaths in the United States increased 11.4% from 2014 to 2015 resulting in 52,404 deaths in 2015, including 33,091 (63.1%) that involved an opioid. The largest rate increases from 2014 to 2015 occurred among deaths involving synthetic opioids other than methadone (synthetic opioids) (72.2%) (1). Because of demographic and geographic variations in overdose deaths involving different drugs (2,3),† CDC examined age-adjusted death rates for overdoses involving all opioids, opioid subcategories (i.e., prescription opioids, heroin, and synthetic opioids),§ cocaine, and psychostimulants with abuse potential (psychostimulants) by demographics, urbanization levels, and in 31 states and the District of Columbia (DC). There were 63,632 drug overdose deaths in 2016; 42,249 (66.4%) involved an opioid.¶ From 2015 to 2016, deaths increased across all drug categories examined. The largest overall rate increases occurred among deaths involving cocaine (52.4%) and synthetic opioids (100%), likely driven by illicitly manufactured fentanyl (IMF) (2,3). Increases were observed across demographics, urbanization levels, and states and DC. The opioid overdose epidemic in the United States continues to worsen. A multifaceted approach, with faster and more comprehensive surveillance, is needed to track emerging threats to prevent and respond to the overdose epidemic through naloxone availability, safe prescribing practices, harm-reduction services, linkage into treatment, and more collaboration between public health and public safety agencies.
引用
- Seth P, Scholl L, Rudd RA, et al. Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016. MMWR Morb Mortal Wkly Rep. 2018. PMID: 29596405. doi:10.15585/mmwr.mm6712a1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。